About Active Pharmaceutical Ingredients Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis. TechNavio's analysts forecast the API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019.
Covered in this Report This report covers the present scenario and the growth prospects of the API market in India during the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process and area of therapy. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. TechNavio's report, the API Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
Key Vendors • Aurobindo Pharma • Cipla • Dr. Reddy's Laboratories Other Prominent Vendors
• Anuh Pharma • Alembic Pharmaceuticals • A. R. Life Sciences • Atul Bioscience • Biocon • Cadila Pharmaceuticals • Calyx Chemicals & Pharmaceuticals • CIRON Drugs and Pharmaceuticals • CTX Life Sciences • Dishman Pharmaceuticals & Chemicals • Elder Pharmaceuticals • Emcure Pharmaceuticals • FDC • Glenmark Pharmaceuticals • Hetero Drugs • Hikal • Ind-Swift Laboratories • Ipca Laboratories • J. B. Chemicals and Pharmaceuticals • Laurus Labs • Lupin • Mangalam Drugs & Organics • Mylan Laboratories • Orchid Chemicals and Pharmaceuticals • Ranbaxy Laboratories • Sandoz • Sequent Scientific • Shasun Pharmaceuticals • Sterling Biotech • Sun Pharmaceutical Industries • The Piramal Group • Torrent Pharmaceuticals • Unichem Laboratories • Wockhardt
Market Driver • Strong Preference for Generic Drugs • For a full, detailed list, view our report
Market Challenge • Regulatory Ban • For a full, detailed list, view our report
Market Trend • Emergence of Africa • For a full, detailed list, view our report
Key Questions Answered in this Report • What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
Our reports have been used by over 10K customers, including:
120 pages •
By Infiniti Research Limited
• Jun 2021
Aesthetic Laser and Energy Devices Market in the US 2021-2025 The analyst has been monitoring the aesthetic laser and energy devices market in the US and it is poised to grow by $ 173.47 million during 2021-2025, progressing at a CAGR of almost 5% during the forecast period. Our report on aesthetic laser and energy devices market in the...
The global empty capsules market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period. The overall growth of the empty capsules market is largely driven by the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical...
529 pages •
By Global Industry Analysts
• Apr 2021
- Global Drug Discovery Technologies Market to Reach $74.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Drug Discovery Technologies estimated at US$44.2 Billion in the year 2020, is projected to reach a revised size of US$74.3 Billion by 2027, growing at aCAGR of 7.7% over the period...
The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8% from 2021 to 2026. Growth in this market is driven by the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, and the growing prevalence of diseases Microplate...
120 pages •
By Infiniti Research Limited
• Apr 2021
Global In Situ Hybridization (ISH) Market 2021-2025 The analyst has been monitoring the in situ hybridization (ISH) market and it is poised to grow by $ 475.05 mn during 2021-2025, progressing at a CAGR of about 7% during the forecast period. Our report on in situ hybridization (ISH) market provides a holistic analysis,...
The ePRO, ePatient diaries, and eCOA market in Asia Pacific is expected to grow from US$ 348.8 million in 2021 to US$ 964.2 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028. Healthcare systems are experiencing a rise in consumer engagement worldwide. In developing countries, health care systems are becoming more...
The ePRO, ePatient Diaries, and eCOA market in Europe is expected to grow from US$ 447.8 million in 2021 to US$ 1,184.3 million by 2028; it is estimated to grow at a CAGR of 14.9% from 2021 to 2028. As per the data provided by Clinicaltrials.gov, 2016 has been a big one for clinical research. There were around 366 thousand clinical studies...
The ePRO, ePatient Diaries, and eCOA market in Middle East and Africa is expected to grow from US$ 48.4 million in 2021 to US$ 112.3 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Increasing number of smartphone users is likely to boost the ePRO, e-Patient Diaries, and eCOA’s adoption in the coming years. Mobile-enabled...
The ePRO, ePatient Diaries, and eCOA market in South and Central America is expected to grow from US$ 90.3 million in 2021 to US$ 229.0 million by 2028; it is estimated to grow at a CAGR of 14.2% from 2021 to 2028. Patient centricity means designing a treatment, clinical trial, or other health solution centered around the patient. Creating...
5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021 Summary 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - 5-Hydroxytryptamine receptor 2B (5-HT2B) or serotonin receptor 2B is a protein encoded by the HTR2B gene. It plays a role in the regulation of behavior,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.